Introduction
The Fifth World Symposium on Pulmonary Hypertension

https://doi.org/10.1016/j.jacc.2013.10.030Get rights and content
Under an Elsevier user license
open archive

Key Words

Fifth World Symposium
pulmonary arterial hypertension
pulmonary hypertension

Cited by (0)

Dr. Galiè has served on the advisory boards of and received lecture fees from Eli Lilly, Actelion, Pfizer, Bayer-Schering, GlaxoSmithKline, and Novartis; and has received institutional grant support from Actelion, Pfizer, Bayer-Schering, GlaxoSmithKline, and Novartis. Dr. Simonneau has served on the advisory boards of Eli Lilly, Actelion, Pfizer, Bayer-Schering, GlaxoSmithKline, and Novartis; has received lecture fees from Eli Lilly, Pfizer, Bayer-Schering, and GlaxoSmithKline; and has received institutional grant support from Actelion, Pfizer, Bayer-Schering, GlaxoSmithKline, and Novartis.